Dr. Stephen V. Liu
Claim this profileMedStar Georgetown University Hospital
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
15 reported clinical trials
26 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage III
EGFR positive
2Non-Small Cell Lung Cancer
Stage IV
Stage III
EGFR positive
Affiliated Hospitals
Clinical Trials Stephen V. Liu is currently running
Ipatasertib + Immunotherapy
for Head and Neck Cancer
This trial is testing whether adding a new drug, ipatasertib, to an existing treatment, pembrolizumab, can better treat head and neck cancer that has returned or spread. Ipatasertib may help stop cancer growth, and pembrolizumab helps the immune system attack the cancer. The goal is to see if this combination works better than using pembrolizumab alone. Pembrolizumab has been used in combination with chemotherapy for various cancers, including head and neck cancer, and has shown improved overall survival and response rates.
Recruiting1 award Phase 225 criteria
Disitamab Vedotin + Tucatinib
for Breast Cancer
This clinical trial is studying solid tumor cancers. A solid tumor is one that starts in part of your body like your lungs or liver instead of your blood. Once they've grown bigger in one spot or spread to other parts of the body, they're harder to treat. This is called advanced or metastatic cancer. Participants in this study must have breast cancer or gastric cancer. Participants must have tumors that have HER2 on them. This allows the cancer to grow more quickly or spread faster. There are few treatment options for patients with advanced or metastatic solid tumors that express HER2. This clinical trial uses an experimental drug called disitamab vedotin (DV). Disitamab vedotin is a type of antibody drug conjugate or ADC. ADCs are designed to stick to cancer cells and kill them. This clinical trial uses a drug called tucatinib, which has been approved to treat cancer in the United States and some other countries. This drug is sold under the brand name TUKYSA®. This study will test how safe and how well DV, with or without tucatinib, is for participants with solid tumors. This study will also test what side effects happen when participants take these drugs. A side effect is anything a drug does to the body besides treating the disease.
Recruiting1 award Phase 1 & 26 criteria
More about Stephen V. Liu
Clinical Trial Related7 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Stephen V. Liu has experience with
- Pembrolizumab
- Nivolumab
- Carboplatin
- Paclitaxel
- Pemetrexed
- BMS-986442
Breakdown of trials Stephen V. Liu has run
Lung Cancer
Non-Small Cell Lung Cancer
Tumors
Solid Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Stephen V. Liu specialize in?
Stephen V. Liu focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Stephen V. Liu currently recruiting for clinical trials?
Yes, Stephen V. Liu is currently recruiting for 8 clinical trials in Washington District of Columbia. If you're interested in participating, you should apply.
Are there any treatments that Stephen V. Liu has studied deeply?
Yes, Stephen V. Liu has studied treatments such as Pembrolizumab, Nivolumab, Carboplatin.
What is the best way to schedule an appointment with Stephen V. Liu?
Apply for one of the trials that Stephen V. Liu is conducting.
What is the office address of Stephen V. Liu?
The office of Stephen V. Liu is located at: MedStar Georgetown University Hospital, Washington, District of Columbia 20007 United States. This is the address for their practice at the MedStar Georgetown University Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.